NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
3 March 2020
DE-LISTING AND CANCELLATION OF TRADING OF SOPHOS SHARES
Further to the announcement made by Sophos Group plc ("Sophos") and Surf Buyer Limited on 2 March 2020, Sophos today announces that, following an application by Sophos, the Financial Conduct Authority has cancelled the listing of Sophos Shares on the premium listing segment of the Official List and the London Stock Exchange has cancelled the trading of Sophos Shares on the London Stock Exchange's main market for listed securities, in each case with effect from 8:00 a.m. (
Capitalised terms used but not otherwise defined in this announcement have the meanings given to them in the scheme document published on 8 November 2019 in relation to the recommended cash offer by Surf Buyer Limited (a company owned by funds managed and/or advised by Thoma Bravo, LLC) for the entire issued and to be issued share capital of Sophos, effected by way of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006.
Enquiries:
Sophos Group plc |
Tel: +44 (0) 12 3555 9933
|
Tulchan Communications (financial PR adviser to Sophos) |
Tel: +44 (0)20 7353 4200
|
J.P. Morgan Cazenove (lead financial adviser and corporate broker to Sophos) Gary Weiss |
Tel: +44 (0)20 7742 4000 |
Lazard (financial adviser and Rule 3 adviser to Sophos) Cyrus Kapadia |
Tel: +44 (0)20 7187 2000 |
UBS AG London Branch (corporate broker and financial adviser to Sophos) |
Tel: +44 (0)20 7567 8000 |
Finsbury (PR adviser to Bidco and Thoma Bravo) |
Tel: +44 (0)20 7251 3801
|
Goldman Sachs (financial adviser to Bidco and Thoma Bravo) |
|
Important notices
Goldman Sachs International, which is authorised by the PRA and regulated by the FCA and the PRA in the
J.P. Morgan Securities plc, which conducts its
Lazard & Co., Limited ("Lazard"), which is authorised and regulated by the FCA in the
UBS AG London Branch ("UBS") is authorised and regulated by the Financial Market Supervisory Authority in
Further information
This announcement is for information purposes only and is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise nor shall there be any sale, issuance or transfer of securities of Sophos in any jurisdiction in contravention of applicable law. The Acquisition will be implemented solely pursuant to the terms of the Scheme Document (or, if the Acquisition is implemented by way of an Offer, the Offer Document), which contains the full terms and conditions of the Acquisition. Each Shareholder is urged to consult his independent professional adviser immediately regarding the tax consequences of the Acquisition applicable to him.
This announcement does not constitute a prospectus or prospectus equivalent document.
Overseas Shareholders
This announcement has been prepared in accordance with English law, the Takeover Code, the Market Abuse Regulation, the Listing Rules and the Disclosure Guidance and Transparency Rules and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside
The availability of the Acquisition to Sophos Shareholders who are not resident in and citizens of the
This announcement does not constitute an offer to sell or issue or the solicitation of an offer to buy or subscribe for shares in any jurisdiction in which such offer or solicitation is unlawful.
The receipt of cash pursuant to the Acquisition by a US holder of Sophos Shares as consideration for the transfer of its Sophos Shares pursuant to the Scheme will be a taxable transaction for US federal income tax purposes and may also be a taxable transaction under applicable state and local tax laws, as well as foreign and other tax laws. Each US holder of Sophos Shares is strongly advised to consult an appropriately qualified independent professional tax adviser immediately with respect to the tax consequences of the Scheme.
Overseas shareholders should consult their own legal and tax advisers with respect to the legal and tax consequences of the Scheme.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the